最新上傳 | 台灣泌尿科醫學會E-School

MP05-07: Surgical outcomes of different suburethral sling procedures for female stress urinary incontinence

2024-06-11

MP05-06: Real-life treatment outcome of botulinum toxin a injection on overactive bladder and voiding dysfunction in patients with central nervous system lesions

2024-06-11

MP05-04: Comparing microsurgical inguinal varicocelectomy and microsurgical subinguinal varicocelectomy: A systemic review and meta-analysis

2024-06-11

MP05-03: Learning curve for Laparoscopic endoscopic single site total extra-peritoneum inguinal hernia repair

2024-06-11

MP05-02: Outcomes of robot-assisted partial cystectomy: A retrospective study on perioperative parameters and survival analysis in patients with malignant and benign pathology

2024-06-11

MP05-01: Exploring the implementation of the innovative Hugo RASrobot system in robotic-assisted radical prostatectomy: Insights from a single surgeon's practice

2024-06-11

MP04-10: How does MRI affect prebiopsy for prostatectomy upgrade rate?

2024-06-11

MP04-09: Detectability of prostate cancer using 3-Tesla Magnetic Resonance Imaging during Transperineal fusion prostate biopsy

2024-06-11

MP04-08: Prognostic factors of metastatic castration-sensitive prostate cancer(mCSPC) patients under novel hormonal agents (NHAs) treatment: A retrospective study

2024-06-11

MP04-07: Comparison of transperineal software-assisted fusion prostate biopsy and transperineal cognitive fusion prostate biopsy

2024-06-11

MP04-06: The early oncological outcome of neoadjuvant androgen deprivation therapy before radical prostatectomy – a single-center experience and literature review

2024-06-11

MP04-05: The prognostic value of biochemical markers in Radium-223 treated metastatic castration-resistant prostate cancer patients

2024-06-11

MP04-04: Preoperative androgen deprivation therapy for radical prostatectomy and short-term oncological outcomes

2024-06-11

MP04-03: Exploring healthcare policies: A comprehensive analysis of the 24-month medication restrictions for mHSPC

2024-06-11

MP04-02: Preliminary single-hospital experience of androgen receptor pathway inhibitors for non-metastatic castration-resistant prostate cancer

2024-06-11

MP04-01: Interim single-hospital experience of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer

2024-06-11

MP03-10: Adrenal vein sampling and its correlation with image and surgical outcome - a single-center cases series and literature review

2024-06-11

MP03-09: Different treatment patterns and survival outcomes based on Cisplatin eligibility in patients with advanced urothelial carcinoma receiving first-line systemic therapy

2024-06-11

MP03-08: Is neoadjuvant immune checkpoint inhibitors-base treatment beneficial to managements of locally advanced upper tract urothelial carcinoma (UTUC)?

2024-06-11

MP03-07: Survival outcomes and clinical characteristics of variant histology in upper tract urothelial carcinoma

2024-06-11

MP03-06: Analysis for bladder recurrence of upper tract urothelial carcinoma following radical nephroureterectomy with transurethral bladder cuff excision and pluck method

2024-06-11

MP03-05: Development and validation of early recurrence predicting model in patients with localized upper tract urothelial carcinoma treated by radical nephroureterectomy

2024-06-11

MP03-04: Long non-coding RNA OIP5-AS1 modulates upper tract urothelial carcinoma cell migration and invasion through regulating miR-340-5p/versican axis

2024-06-11

MP03-03: Clinical effect of Denosumab in metastatic castration resistant prostate cancer – retrospective observational study

2024-06-11

/ 155